| TAGline |
 |
| about TAG |
|
| Hepatitis/HIV Project |
|
| activism & policy |
|
| TB/HIV project |
|
| science & vaccines |
|
| antiretrovirals |
|
| search |
|
| Would you like to receive TAGline at your home or office? A one-year subscription is $30 for individuals, $50 for institutions. (Subscription is automatic for anyone making annual donations to TAG at or above these amounts.) Send your check or money order, payable to Treatment Action Group, to us at: Treatment Action Group 611 Broadway, Ste. 308 New York, NY 10012-2608 |
- TAGLine Spring 2008
National AIDS Strategy, CROI Webcast Reviews, The Future is Generic, What's in the ARV Pipeline, NIAID convenes HIV vaccine summit, Treatment Complacency (added 06/10/08) - TAGLine Winter 2008
Merck's HIV Vaccine Fails, Interview with Stephen Deeks, The Plan to Fight TB, Talking about a Cure (web format added 02/13/08)2007 - TAG Winter Update 2007
Urgent Need for TB Research Funds, New HIV Drugs for 2007, The Year in Review, TAG in the News, New Federal Policy Director, New TB/HIV Project Coordinator - TAGline September 2007 Vol. 13 No. 1
Rapidly Progressing Hepatitis C in New York Gay Men, The Sitges Statement on HCV Drug Development, FDA Holds Hearing on HCV Drug Development, Antiretroviral Drug Sales: Truvada moves to number one, Improving TB Drug Susceptibility Testing, Basic Research is a Government Responsibility, Time for New Directions in HIV Research2006 - TAGline December 2006 Vol. 12 No. 2
Activist Scolds TB World, Diagnosing and treating multi-drug resistant TB, Hospitals Implicated in Spread of XDR-TB, CD4 depletion theories and possible links to pathogenic immune activation, Tibotec's clinical trial designed with women in mind, Better HIV Drugs Needed, Treating people with HIV/HCV coinfection, Next steps to achieving universal access to HIV therapy - TAG Update Winter 2006
Dear Friends of TAG, Update, In the News, Meeting with Bill and Melinda Gates, TAG's New Editorial Director: Bob Huff, TAG's Newest Board Member: Robert Pini, 2006 Research in Action Awards, Antiretroviral Update, Treatment Interruptions & Intermittent Therapy Research, Michael D. Palm: A Legacy of Generosity (Update added 12/29/06) - What's in the Pipeline?
New HIV Drugs, Vaccines, Microbicides, HCV and TB Treatments in Clinical Trials. July 2006 - Volume 13, Issue 1, April 2006
SMART Stops Stopping, HCV at CROI: Chasm between bench and bedside, Overlapping Epidemics: TB, HIV, viral hepatitis, TB Diagnostic Emergency, Co-receptor Conundrum (added 5/11/06)2005 - TAG Update Fall 2005
Interview with Javid Syed, TAG TB/HIV Project Director; TAG board member Rich Lynn, Ph.D., nominated for an Out & Equal Workplace Award, TAG in the News; Join TAG's Board; Current TAG Reports Available. (Update added 03/02/06) - Volume 12, Issue 1, January 2005
PHS Panel Embraces Treatment Interruption, Squandering Public Goodwill and Scarce Research Funds To Boot, Timeline for the Initiation of the RV144 Prime-Boost Trial, Late 2004 Changes to Federal (DHHS) Treatment Guidelines, Tangle of Interests and Disclosure Omissions Cracks Authors' Case For Early, Aggressive Treatment, Brown University Clinician Leads the Way In Providing Competent Care To Coinfected Injectors, Letters to the Editor (added 1/19/05) - Volume 11, Issue 11, December 2004
Questioning the firewall, Does Gilead's Famed 903 Study Really Show You What They Tell You It Shows? Cell Therapy aka Therapeutic 'Vaccine' Surprise Announcement for World AIDS Day, Why the Tap 'n' Drainers Have Always Been Wrong; Plus, A New Theory About MDR HIV, Mixed Results (and Lots of Diarrhea) for the Tipranavir Studies; Plus Salvage Study Designs for JNJ/Tibotec's PI and Non-nuke, Who provides you with up-to-date treatment information?
|
Treatment Action Group
611 Broadway, Ste. 308
New York, NY 10012
phone: (212) 253-7922
fax: (212) 253-7923
copyright © 1996-2008 TAG